Drug Metabolism & Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877-0368, USA.
Bioanalysis. 2021 May;13(10):847-860. doi: 10.4155/bio-2020-0252. Epub 2021 Apr 23.
The foundation of pharmacokinetics and antidrug antibodies assay robustness relies on the use of high-quality reagents. Over the past decade, there has been increasing interest within the pharmaceutical industry, as well as regulators, on defining best practices and scientific approaches for generation, characterization and handling of critical reagents. In this review, we will discuss current knowledge and practices on critical reagent workflows and state-of-the-art approaches for characterization, generation, stability and storage and how each of these steps can impact ligand-binding assay robustness.
药代动力学和抗药物抗体分析稳健性的基础依赖于高质量试剂的使用。在过去十年中,制药行业以及监管机构越来越关注定义生成、鉴定和处理关键试剂的最佳实践和科学方法。在这篇综述中,我们将讨论关于关键试剂工作流程的最新知识和实践以及鉴定、生成、稳定性和储存的最新方法,以及这些步骤中的每一步如何影响配体结合分析的稳健性。